Literature DB >> 1582001

Effect of meningococcal endotoxin in a rabbit model of shock.

G L Caputo1, G Baldwin, G Alpert, J Parsonnet, Z A Gillis, G Siber, G Fleisher.   

Abstract

Endotoxin in the form of a lipooligosaccharide (LOS) plays a key role in the development of shock in meningococcal sepsis. To examine hemodynamic and biochemical alterations during meningococcal endotoxic shock, we established a rabbit model. Thirty-nine rabbits, weighing 2.5-4.4 kg, were studied. After anesthesia with intramuscular ketamine (20 mg/kg) and xylazine (4 mg/kg), femoral venous and arterial catheters were inserted. Control animals received only saline, while rabbits in each of four additional groups were given LOS in 10-fold increments from 0.1 microgram/kg to 100 microgram/kg. Mean arterial pressure (MAP), heart rate (HR), respirations (RR), temperature (T), urine output, and arterial blood gases (pH, PCO2, PO2, and bicarbonate) were determined at baseline and hourly. Endotoxin levels and TNF levels were measured at 30, 60, 120, 180, 240, 300, and 360 min post-LOS. Survival was recorded. One-way analysis of variance (ANOVA) and the Scheffe procedure, paired samples t-test, two-tailed t-test, and Fisher's exact test were used. Pearson's coefficients were calculated. Animals receiving meningococcal LOS developed tachycardia and compensated metabolic acidosis with an initially normal pH and MAP. With progression of the shock state, the pH decreased and hypotension ensued. Maximal levels of endotoxin were measured 30 min after LOS injection and declined during the ensuing 6 hr. TNF rose from undetectable to markedly elevated levels and peaked at 60-120 min post-LOS. Increasing the amount of injected endotoxin produced more profound degrees of shock until a dose of 10.0 micrograms/kg was reached. There was no correlation between serum TNF at 60 min and survival at 6 hr or 24 hr.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582001

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  5 in total

Review 1.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Alpha-1-acid (AAG, orosomucoid) glycoprotein: interaction with bacterial lipopolysaccharide and protection from sepsis.

Authors:  D F Moore; M R Rosenfeld; P M Gribbon; C P Winlove; C M Tsai
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

3.  Intranasal delivery of group B meningococcal native outer membrane vesicle vaccine induces local mucosal and serum bactericidal antibody responses in rabbits.

Authors:  David R Shoemaker; Nancy B Saunders; Brenda L Brandt; E Ellen Moran; Andrew D Laclair; Wendell D Zollinger
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  [Clinical course and complications of meningococcal septicemia].

Authors:  F Gradaus; R M Klein; H J von Giesen; G Arendt; M P Heintzen; M Leschke; B E Strauer
Journal:  Med Klin (Munich)       Date:  1999-11-15

5.  Cerebral microcirculation shear stress levels determine Neisseria meningitidis attachment sites along the blood-brain barrier.

Authors:  Emilie Mairey; Auguste Genovesio; Emmanuel Donnadieu; Christine Bernard; Francis Jaubert; Elisabeth Pinard; Jacques Seylaz; Jean-Christophe Olivo-Marin; Xavier Nassif; Guillaume Duménil
Journal:  J Exp Med       Date:  2006-07-24       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.